FDA approves Lorcaserin and Mirabegron extended-release tablets.
Craig I. Coleman, PharmD
Advertisement
Articles by Craig I. Coleman, PharmD
FDA has approved pancrelipase delayed-release capsules to treat exocrine pancreatic insufficiency resulting from cystic fibrosis or other conditions.
FDA approves avanafil and tafluprost
FDA approves Lucinactant and Peginesatide
Advertisement
Latest Updated Articles
- Pancrelipase DR caps approved for EPI
Published: August 10th 2012 | Updated:
- New treatments for obesity and OAB
Published: September 15th 2012 | Updated:
- FDA approves oral inhibitor for ED
Published: July 15th 2012 | Updated:
- Lucinactant approved for premie RDS
Published: June 15th 2012 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Provide Tailored Pneumococcal Vaccines to Patients With Down Syndrome
2
Dementia Increases Risk of COVID-19 Infection, Hospitalization for Older Patients
3
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
4
Pharmacists’ Expanding Roles in Diabetes, Community Health Care
5
